Female breasts are a source of life for a newborn baby. At least, this was the case before: if the mother does not have milk, the child’s life was in real danger of starvation or serious illness due to very low immunity. Now the problem is not so acute, however, this does not mean that you do not need to pay attention to all sorts of diseases that affect the female breast.
To combat such diseases, a mass of a wide variety of medicines has been developed to date, one of which is Mamoklam. Reviews of mammologists characterize the drug as an effective tool in the treatment of fibrocystic mastopathy, mastalgia, regression of cysts.
The composition of the medication
The origin of “Mamoklama” is directly related to wildlife. The raw material for the manufacture of the drug is kelp - seaweed. The collected plants undergo a rather complicated treatment, during which the kelp is dried, crushed, and extracted with ethyl alcohol with the addition of water. The extractant thus isolated is subjected to regeneration.
The residue obtained as a result of this process is divided into two fractions - lipid and water, respectively, concentrate and kelp extract. The lipid fraction is hydrolyzed, the result of which is the substance "Klam". This is one of the main components of the Mamoklam drug. The composition of the drug also includes lipids (0.040 g of omega-3 polyunsaturated fatty acids), 10 mg chlorophyll and iodine (0.1 mg) in an organically bound form.
A certain set of substances acts as auxiliary components: sugar - milk and refined, microcrystalline and methyl cellulose, compounds of magnesium, calcium, titanium dioxide, copper derivatives of chlorophyll.
Clinical studies have shown the high effectiveness of the drug Mamoklam. The medicine does not have any toxic effects on the human body. Its use does not cause hormonal imbalance.
Release Forms
The manufacturer offers the drug Mamoklam to its customers in the form of biconvex tablets, coated with a light green shade. The drug can be packaged in either blisters or in glass (dark shades) jars. The number of tablets in both types of packaging can be different. For example, 20 tablets can be packaged in dark glass jars as well as in blister packs (blisters). Buyers can also purchase 30 units of medicine in dark glass jars, while 40 units are packaged in polymer cans.
If you need to buy only 10 tablets, then they are offered to patients only in blister packs - blisters, packed in a cardboard box.
Pharmacodynamics and pharmacokinetics
The Mamoklam medication is described by mammologists as an effective remedy for fibrocystic mastopathy, which relieves pain in the mammary gland, significantly reduces the manifestations of premenstrual tension.
As for pharmacokinetics, the effect of the drug on the human body is due to the combined effect of all the components of the drug on it. In this regard, the conduct of kinetic studies is not feasible: there is no way to track the influence of all components through markers or biological studies. For the same reason, it is not possible to identify the metabolites of Mamoklama.
Indications and contraindications for use
The main area of ​​effect of the drug is fibrocystic mastopathy. "Mamoklam", according to experts, is an effective remedy for this disease, manifested in the pathological proliferation of connective tissue of the female breast. Mastopathy originates on the background of hormonal imbalance in the female body. This condition can occur in the presence of inflammatory diseases of the female genital area or genital infections, after abortion or refusal of breastfeeding. If no measures are taken, then a treatable mastopathy can transform into a malignant process.
Quite often, this drug can be prescribed by a doctor to normalize the menstrual cycle, alleviate the symptoms of premenstrual syndrome and with painful periods (algomenorrhea). A positive effect can be achieved by using Mamoklam to stimulate the restoration of the balance of thyroid and sex hormones in the body.
Mamoklam is also effective for manifestations of mastalgia (pain in the mammary gland), stimulates cyst regression, and normalizes proliferation processes (proliferation of body tissue through cell division) of the mammary gland epithelium.
As a contraindication, there is a fairly extensive area of ​​a wide variety of diseases. Do not prescribe medication for patients with kidney diseases and hyperthyroidism (a disorder that stimulates increased secretion of hormones), for multinodular goiter and thyrotoxicosis of various origins (Bazedova’s disease, many nodes whose cells secrete a lot of hormones, toxic thyroid adenoma , etc. .). Even if none of the above diagnoses is established, but certain symptoms are observed, the treating doctor should be aware of this. Of the most striking symptoms, one can distinguish such as increased appetite, peeling of nails, menstrual irregularities, severe reactions to overheating, weakness, suffocation, excessive sweating and a tendency to diarrhea, excessive nervous excitement and excessive motor activity.
A contraindication for taking "Mamoklama" is the presence of pregnancy or the period of breastfeeding. It goes without saying that one should not discount such a factor as hypersensitivity to the components of the drug.
Dosage and Administration
The drug "Mamoklam" instructions for use regulate oral administration. The optimal time for admission is before meals. The duration of the course of therapy is the prerogative of the attending physician, who must take into account all the nuances: the state of health of his ward, and individual tolerance (or intolerance) and the presence of concomitant diseases, and, accordingly, the therapy used against them.
The standard dosage regimen is the optimal answer to the question of how to take Mamoklam. It lies in the plane of a 2-3-fold medication for 1-2 tablets. The effect will be more positive if the drug is taken at regular intervals. However, patients need to know that more than 6 tablets are not recommended during the day. Usually, the course of therapy lasts from one to three months. If for some reason the therapy needs to be repeated (the decision must come from the doctor), this can be done no earlier than 2-9 weeks later. Repeatedly (and not only) take "Mamoklam" application instruction recommends under the supervision of a treating doctor.
Medical specialists are of the opinion that if after the first course of therapy there is a final recovery, to consolidate the effect and for prevention, it will be advisable to repeat the treatment after a few months.
Reasonably high dose: consequences
To date, no cases of overdose have been recorded. However, if for any reason an unjustifiably large dose of Mamoklam is taken at the same time (patient reviews rarely reported such cases), you must try to do a gastric lavage. To do this, you need to drink a large amount of water in order to provoke a gag reflex.
If the patient feels obvious discomfort, it is better not to take risks, but to seek help at a medical institution or call a doctor at home. The specialist will evaluate the state of health and prescribe the necessary treatment measures to eliminate the painful symptoms.
Undesirable manifestations
As a rule, regarding the use of the Mamoklam preparation, reviews of mammologists most often speak of various allergic reactions to the skin in the form of redness, itching, rashes. Next, it should be said about the possibility of developing dyspeptic manifestations. From patients, you can hear complaints about the appearance of heartburn, flatulence. Characteristic during this period is the manifestation of disorders in the functioning of the intestine - diarrhea. A certain group of patients reports that with a sufficiently long-term use of "Mamoklama" iodism symptoms developed, manifested in the appearance of a runny nose, salivation and lacrimation, and acne. In severe cases, the development of such a dangerous process as Quincke's edema is possible.
With the development of all the above manifestations, the most optimal solution would be to consult your doctor for advice.
Special instructions to consumers
The composition of the drug includes a sufficiently large dose of iodine, significantly exceeding the daily amount of this substance necessary for the human body. For this reason, during treatment with Mamoklam, the instructions for use, reviews of medical experts recommend that you refrain from taking any more iodine-containing medicines.
Patients should be aware that when storing tablets under conditions different from those indicated in the instructions for use, the physicochemical properties of the drug undergo changes in a negative direction. Pills can change the color tone, start to crumble and eventually lose their healing properties. If anything like this takes place, you should refuse to take such a drug.
According to experts, "Mamoklam", the use of which has already been sufficiently studied, with proper admission and following the doctor's recommendations, practically does not cause the development of any negative reactions. However, a quick optimal effect from the treatment with Mamoklam can be achieved if the disease is at an initial stage when there are still no rough foci of connective tissue and large cysts in the breast tissue. Otherwise, the course of treatment will be quite long, "Mamoklam" will need to be used as a component of complex therapy.
In addition, if the cause of the development of problems in the mammary glands is hormonal imbalance and pathological processes in the ovaries, “Mamoklam” should be taken in combination with contraceptive hormonal contraceptives. Such a tandem of drugs will relieve the female body from hormonal fluctuations and stabilize the menstrual cycle.
Analog medicines
A sufficiently large number of drugs have a match according to the ATX code of the 4th level with the drug "Mamoklam". Instructions, reviews of experts report in this regard about such medicines as Klimadinon, Klimadinon Uno, Triozhinal, Tsi-Klim, Cyclodinon and many others.
In pharmacies, consumers are most often offered analogue medicines such as Mammoleptin, Tazalok, Utrozhestan, Mastofit, Indol Forte Evalar, Mastofemin.
The greatest consumer demand from all analogues of Mamoklama is Mastodinon.
Both drugs are homeopathic complexes, however, their effect in each specific case may differ from each other. If the question of choice arises, in the presence of concomitant thyroid diseases, Mastodinon is usually preferred. If we are talking about women without such problems, then oncologists, as a rule, are inclined towards the drug "Mamoklam." Reviews of specialists in such cases characterize it as more effective.
Opinion about the drug
Opinions on the use of the drug "Mamoklam" exist in different directions. On the part of consumers, the bulk of the reviews is positive. The drug effectively fights manifestations of mastalgia and mastopathy, the results are usually visible after a few weeks from the start of therapy. It is often reported that the use of "Mamoklama" contributed to the elimination of disease symptoms and recovery.
About the Mamoklam drug, reviews of mammologists report that they are often prescribed to women who refuse hormonal therapy. After all, this drug in its composition is a phytopreparation that does not do any harm to the body, its administration does not entail an increase in body weight and does not provoke changes in the menstrual cycle.
Negative reviews about "Mamoklam" are rare. Side effects rarely develop, this is usually provoked either by non-compliance with the doctor’s recommendations or by individual hypersensitivity (there is nothing to be done about it, you will have to refuse the use of the drug and replace it with another). In any case, patients should keep in mind that various undesirable effects can develop with prolonged use of the Mamoklam medication and, as a result, with the oversaturation of the body with iodine.
Medical experts strongly do not recommend making a decision on treatment with Mamoklam on their own. The most important rule in this case is a preliminary visit to the doctor.